Annual Drug Patent Expirations for BRIDION
Bridion is a drug marketed by Organon Sub Merck and is included in one NDA. It is available from one supplier. There are three patents protecting this drug.
Drug patent litigation for BRIDION.
This drug has fifty-four patent family members in thirty countries.
The generic ingredient in BRIDION is sugammadex sodium. One supplier is listed for this compound. Additional details are available on the sugammadex sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
